Revisiting Tyler Perry’s on-screen work beyond his own productions

From 'Gone Girl' to 'Star Trek,' the filmmaker’s acting credits beyond his empire prove he’s more versatile than people think ...

Engineered Natural Killer Cells Evade Rejection in Cancer Therapy

Researchers have now come up with a new way to engineer CAR-NK cells that makes them much less likely to be rejected by the ...
PharmiWeb

FDA Approves Libtayo as First Immunotherapy for Adjuvant Treatment of CSCC

Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence interval: 0.

Libtayo® (cemiplimab-rwlc) Approved in the U.S. as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research from more than 100 ...